Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for Alvotech (ALVO) over the last 4 years, with Q3 2025 value amounting to -$39.5 million.

  • Alvotech's Cash from Investing Activities fell 27338.81% to -$39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$107.3 million, marking a year-over-year decrease of 21419.66%. This contributed to the annual value of -$18.9 million for FY2024, which is 5928.36% up from last year.
  • According to the latest figures from Q3 2025, Alvotech's Cash from Investing Activities is -$39.5 million, which was down 27338.81% from -$28.6 million recorded in Q2 2025.
  • Over the past 5 years, Alvotech's Cash from Investing Activities peaked at $22.8 million during Q3 2024, and registered a low of -$63.5 million during Q4 2022.
  • Over the past 4 years, Alvotech's median Cash from Investing Activities value was -$13.9 million (recorded in 2023), while the average stood at -$19.4 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 31358.3% in 2024, then plummeted by 48606.32% in 2025.
  • Alvotech's Cash from Investing Activities (Quarter) stood at -$63.5 million in 2022, then rose by 27.07% to -$46.3 million in 2023, then skyrocketed by 59.28% to -$18.9 million in 2024, then plummeted by 109.09% to -$39.5 million in 2025.
  • Its Cash from Investing Activities stands at -$39.5 million for Q3 2025, versus -$28.6 million for Q2 2025 and -$20.4 million for Q1 2025.